
Syfovre gets FDA approval for GA
Apellis’ Syfovre (pegcetacoplan injection) has become the first US Food and Drug Administration (FDA) -approved treatment for geographic atrophy (GA) secondary to age-related macular degeneration

Apellis’ Syfovre (pegcetacoplan injection) has become the first US Food and Drug Administration (FDA) -approved treatment for geographic atrophy (GA) secondary to age-related macular degeneration

Focusing on ophthalmology and endoscopy, a new private surgical centre, Kāpiti Day Hospital, is set to open its doors in June.

The University of Auckland (UoA) is collaborating with Fred Hollows Foundation New Zealand to undertake a new and ambitious Pacific-focused research programme.

Partnering with elegant and understated French clothing brand, Officine Générale, Garrett Leight California Optical (GLCO) has created a limited-edition frame blending French and Californian style suited to optical and sun wear.

Researchers in China have identified a small molecule which restores visual function following optic nerve damage.

Archway randomised phase 3 trial of ranibizumab port delivery system for nAMDHolekamp N et alOphthalmology, 2022. 129(3): p. 295-307

The US developers of a smart contact lens (CL) claim it will continuously monitor intraocular pressure (IOP) in glaucoma patients, even as they sleep.

Building on the release of its Wireframe campaign, the new Blackfin One optical collection follows in its tracks with an exclusive stylistic expression.

Australia and New Zealand have some of the longest healthcare waiting times in the OECD, second and fifth from the bottom, respectively, a new study has found.

Canadian researchers investigating why only some genetically predisposed individuals develop age-related macular degeneration (AMD) have found obesity leads to persistent changes in immune-cell DNA, making the cells more susceptible to producing inflammatory molecules.

Backed by Bayer Spain, Barcelona’s Right Care Foundation (RCF) is using Auckland’s Toku Eyes’ AI platform to train doctors in early detection of diseases through retinal imaging.

Glaucoma New Zealand (GNZ) is running a comprehensive awareness campaign leading up to this year’s World Glaucoma Week (12-18 March) encouraging 40-year-olds to seek out their local optometrist and get an eye test.
